Suscribirse

Association between radiographic and functional outcome in vertebral osteomyelitis SPONDIMMO, a 6-month prospective multicenter cohort - 30/11/23

Doi : 10.1016/j.jbspin.2023.105600 
Marie Chevalerias a, ⁎ , Guillaume Coiffier b, Christelle Darrieutort-Laffite a, Sophie Godot c, Sebastien Ottaviani d, Julien Henry e, Julia Brochard f, Grégoire Cormier g, Marion Couderc h, Emmanuel Hoppe i, Denis Mulleman j, Lydie Khatchatourian k, Aurélie Le Thuaut l, Géraldine Bart m, Benoit Le Goff a
a Department of Rheumatology, CHU de Nantes, Nantes, France 
b Department of Rheumatology, CH de Saint-Malo, Saint-Malo, France 
c Department of Rheumatology, AP–HP DCSS, Paris, France 
d Department of Rheumatology, AP–HP Bichat, Paris, France 
e Department of Rheumatology, AP–HP Bicêtre, Paris, France 
f Department of Infectious Diseases, CH de Saint-Nazaire, Saint-Nazaire, France 
g Department of Rheumatology, CHD de Vendée, La Roche-sur-Yon, France 
h Department of Rheumatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France 
i Department of Rheumatology, CHU d’Angers, Angers, France 
j Department of Rheumatology, CHU de Tours, Tours, France 
k Department of Internal Medicine and Infectious Disease, CH de Cornouaille, Quimper, France 
l Direction of Research, Methodology and Biostatistics Platform, CHU de Nantes, Nantes, France 
m Department of Rheumatology and Internal Medicine, Percy Military Training Hospital, Paris, France 

⁎Corresponding author.

Highlights

•
After 3 months, all the radiographic features worsened.
•
Between 3 and 6 months, among the different X-ray abnormalities, only the complete fusion progressed.
•
Sixteen percent of the patients with vertebral osteomyelitis (VO) still present with a severe to major disability at 6 months.
•
Vertebral destruction was associated with a higher disability at 6 months.
•
No differences in radiological progression were observed depending on immobilization.

El texto completo de este artículo está disponible en PDF.

Abstract

Objectives

This study aimed to describe radiographic and functional evolution over 6 months in a large cohort of VO patients.

Methods

We prospectively recruited patients with VO from 2016 to 2019 in 11 French centers. X-rays were performed at baseline, 3 months, and 6 months to assess progression using structural and static criteria. Functional impairment was evaluated using the Oswestry Disability Index (ODI) at 3 months and 6 months.

Results

Two hundred and twenty-two patients were included. Mean age was 67.8±14 years, mostly men (67.6%). After 3 months, there was a significant increase in vertebral fusion (16.4% vs 52.7%), destruction of vertebral bodies (10.1% vs 22.8%), and of all the static features (frontal angulation (15.2% vs 24.4%), segmental (34.6% vs 56%) and regional (24.5% vs 41%) kyphosis). From 3 to 6 months, among the different X-ray abnormalities, only the complete fusion progressed significantly (16.6% vs 27.2%). Median ODI showed significant improvement from 3 to 6 months (24, IQR [11.5–38] vs 16, IQR [6–34]). At 6 months, 14.1% of the patients had a severe disability, 2% a major disability. The persistence of vertebral destruction at 6 months was associated with a higher ODI (16, IQR [7.5–30.5] vs 27, IQR [11.5–44.5]). No differences in radiological progression were observed with immobilization using a rigid brace.

Conclusion

Our study demonstrates structural and static radiographic progression after 3 months. Only the complete fusion progressed over the long-term. Functional impairment was associated with persistence of vertebral destruction.

El texto completo de este artículo está disponible en PDF.

Keywords : Vertebral osteomyelitis, Spondylodiscitis, X-ray, Radiography, Follow-up


Esquema


© 2023  Société française de rhumatologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 90 - N° 6

Artículo 105600- décembre 2023 Regresar al número
Artículo precedente Artículo precedente
  • Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
  • Claire Amigues, Audrey Fresse, Christian Hubert Roux, Sophie Gauthier, Marie-Hélène Vieillard, Milou-Daniel Drici, Véronique Breuil, French Network of Pharmacovigilance Centers
| Artículo siguiente Artículo siguiente
  • Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach
  • Guillaume Larid, Simon Valayer, Clémentine Jacquier, Pierre Lafforgue, Jean Denis Laredo, Thao Pham

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.